Trials / Terminated
TerminatedNCT02032862
Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating
Multicentric, Randomized, Double Blind Study for Assessment of Efficacy and Tolerability of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- A. Vogel AG · Industry
- Sex
- Female
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Sage tablets ( 3400 mg extract from fresh sage leaves, DER 1:17) in a once daily application over 12 treatment weeks are compared against placebo in 200 menopausal patients with ≥ 5 hot flushes daily and a Hyperhidrosis Scale score ≥ 2
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sage extract, 3400 mg , DER 1:17 |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-01-10
- Last updated
- 2015-07-21
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02032862. Inclusion in this directory is not an endorsement.